Anti-SCN2B/ ATFB14 monoclonal antibody

Anti-SCN2B/ ATFB14 antibody for FACS & in-vivo assay

Target products collectionGo to SCN2B/SCN2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1488-Ab-1/ GM-Tg-hg-MP1488-Ab-2Anti-Human SCN2B monoclonal antibodyHuman
GM-Tg-rg-MP1488-Ab-1/ GM-Tg-rg-MP1488-Ab-2Anti-Rat SCN2B monoclonal antibodyRat
GM-Tg-mg-MP1488-Ab-1/ GM-Tg-mg-MP1488-Ab-2Anti-Mouse SCN2B monoclonal antibodyMouse
GM-Tg-cynog-MP1488-Ab-1/ GM-Tg-cynog-MP1488-Ab-2Anti-Cynomolgus/ Rhesus macaque SCN2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1488-Ab-1/ GM-Tg-felg-MP1488-Ab-2Anti-Feline SCN2B monoclonal antibodyFeline
GM-Tg-cang-MP1488-Ab-1/ GM-Tg-cang-MP1488-Ab-2Anti-Canine SCN2B monoclonal antibodyCanine
GM-Tg-bovg-MP1488-Ab-1/ GM-Tg-bovg-MP1488-Ab-2Anti-Bovine SCN2B monoclonal antibodyBovine
GM-Tg-equg-MP1488-Ab-1/ GM-Tg-equg-MP1488-Ab-2Anti-Equine SCN2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1488-Ab-1/ GM-Tg-hg-MP1488-Ab-2; GM-Tg-rg-MP1488-Ab-1/ GM-Tg-rg-MP1488-Ab-2;
GM-Tg-mg-MP1488-Ab-1/ GM-Tg-mg-MP1488-Ab-2; GM-Tg-cynog-MP1488-Ab-1/ GM-Tg-cynog-MP1488-Ab-2;
GM-Tg-felg-MP1488-Ab-1/ GM-Tg-felg-MP1488-Ab-2; GM-Tg-cang-MP1488-Ab-1/ GM-Tg-cang-MP1488-Ab-2;
GM-Tg-bovg-MP1488-Ab-1/ GM-Tg-bovg-MP1488-Ab-2; GM-Tg-equg-MP1488-Ab-1/ GM-Tg-equg-MP1488-Ab-2
Products NameAnti-SCN2B monoclonal antibody
Formatmab
Target NameSCN2B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SCN2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SCN2B/ ATFB14 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP000176human SCN2B Lentivirus particle
    ORF Viral VectorpGMLP000176human SCN2B Lentivirus plasmid
    ORF Viral VectorpGMLPm000441mouse Scn2b Lentivirus plasmid
    ORF Viral VectorvGMLPm000441mouse Scn2b Lentivirus particle


    Target information

    Target IDGM-MP1488
    Target NameSCN2B
    Gene ID6327,72821,25349,678698,538722,100062848
    Gene Symbol and Synonyms2810451E09Rik,ATFB14,Gm183,SCN2B,SCNB2
    Uniprot AccessionO60939,P54900,Q864L3
    Uniprot Entry NameSCN2B_HUMAN,SCN2B_RAT,SCN2B_CANLF
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000149575
    Target ClassificationN/A

    The target: SCN2B, gene name: SCN2B, also named as ATFB14. The protein encoded by this gene is the beta 2 subunit of the type II voltage-gated sodium channel. The encoded protein is involved in cell-cell adhesion and cell migration. Defects in this gene can be a cause of Brugada Syndrome, atrial fibrillation, or sudden infant death syndrome. [provided by RefSeq, Jul 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.